These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26639052)

  • 1. CD147 monoclonal antibody mediated by chitosan nanoparticles loaded with α-hederin enhances antineoplastic activity and cellular uptake in liver cancer cells.
    Zhu R; Zhang CG; Liu Y; Yuan ZQ; Chen WL; Yang SD; Li JZ; Zhu WJ; Zhou XF; You BG; Zhang XN
    Sci Rep; 2015 Dec; 5():17904. PubMed ID: 26639052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
    Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ
    Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity.
    Khan MW; Zhao P; Khan A; Raza F; Raza SM; Sarfraz M; Chen Y; Li M; Yang T; Ma X; Xiang G
    Int J Nanomedicine; 2019; 14():3753-3771. PubMed ID: 31239661
    [No Abstract]   [Full Text] [Related]  

  • 4. CD147 Monoclonal Antibody Targeted Reduction-Responsive Camptothecin Polyphosphoester Nanomedicine for Drug Delivery in Hepatocellular Carcinoma Cells.
    Tian H; Huang Y; He J; Zhang M; Ni P
    ACS Appl Bio Mater; 2021 May; 4(5):4422-4431. PubMed ID: 35006854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Hederin induces paraptosis by targeting GPCRs to activate Ca
    Rao X; Li Z; Zhang Q; Lai Y; Liu J; Li L; Cheng H; Shen W; Sun D
    Cancer Med; 2024 Apr; 13(8):e7202. PubMed ID: 38659391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-trimethyl chitosan nanoparticle-encapsulated lactosyl-norcantharidin for liver cancer therapy with high targeting efficacy.
    Guan M; Zhou Y; Zhu QL; Liu Y; Bei YY; Zhang XN; Zhang Q
    Nanomedicine; 2012 Oct; 8(7):1172-81. PubMed ID: 22321383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma.
    Shi L; Tang C; Yin C
    Biomaterials; 2012 Oct; 33(30):7594-604. PubMed ID: 22796165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidant studies of chitosan nanoparticles containing naringenin and their cytotoxicity effects in lung cancer cells.
    Kumar SP; Birundha K; Kaveri K; Devi KT
    Int J Biol Macromol; 2015; 78():87-95. PubMed ID: 25840152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-delivery of Gefitinib and chloroquine by chitosan nanoparticles for overcoming the drug acquired resistance.
    Zhao L; Yang G; Shi Y; Su C; Chang J
    J Nanobiotechnology; 2015 Sep; 13():57. PubMed ID: 26395758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and tumor cytotoxicity of novel amide derivatives of β-hederin.
    Liu Y; Lu WX; Yan MC; Yu Y; Ikejima T; Cheng MS
    Molecules; 2010 Nov; 15(11):7871-83. PubMed ID: 21060295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Delivery of Doxorubicin via CD147-Mediated ROS/pH Dual-Sensitive Nanomicelles for the Efficient Therapy of Hepatocellular Carcinoma.
    Qu C; Li J; Zhou Y; Yang S; Chen W; Li F; You B; Liu Y; Zhang X
    AAPS J; 2018 Feb; 20(2):34. PubMed ID: 29476273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-density lipoprotein-coupled N-succinyl chitosan nanoparticles co-delivering siRNA and doxorubicin for hepatocyte-targeted therapy.
    Zhu QL; Zhou Y; Guan M; Zhou XF; Yang SD; Liu Y; Chen WL; Zhang CG; Yuan ZQ; Liu C; Zhu AJ; Zhang XN
    Biomaterials; 2014 Jul; 35(22):5965-76. PubMed ID: 24768047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin-loaded biocompatible thermoresponsive polymeric nanoparticles for cancer drug delivery.
    Rejinold NS; Muthunarayanan M; Divyarani VV; Sreerekha PR; Chennazhi KP; Nair SV; Tamura H; Jayakumar R
    J Colloid Interface Sci; 2011 Aug; 360(1):39-51. PubMed ID: 21549390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis.
    Sun P; Huang W; Jin M; Wang Q; Fan B; Kang L; Gao Z
    Int J Nanomedicine; 2016; 11():4931-4945. PubMed ID: 27729789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial pathway mediated by reactive oxygen species involvement in α-hederin-induced apoptosis in hepatocellular carcinoma cells.
    Li J; Wu DD; Zhang JX; Wang J; Ma JJ; Hu X; Dong WG
    World J Gastroenterol; 2018 May; 24(17):1901-1910. PubMed ID: 29740205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.
    Gu J; Al-Bayati K; Ho EA
    Drug Deliv Transl Res; 2017 Aug; 7(4):497-506. PubMed ID: 28315051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trans-resveratrol loaded chitosan nanoparticles modified with biotin and avidin to target hepatic carcinoma.
    Bu L; Gan LC; Guo XQ; Chen FZ; Song Q; Qi-Zhao ; Gou XJ; Hou SX; Yao Q
    Int J Pharm; 2013 Aug; 452(1-2):355-62. PubMed ID: 23685116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, characterization and cytotoxicity studies of chitosan-coated tea polyphenols nanoparticles.
    Liang J; Li F; Fang Y; Yang W; An X; Zhao L; Xin Z; Cao L; Hu Q
    Colloids Surf B Biointerfaces; 2011 Feb; 82(2):297-301. PubMed ID: 20888740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan/PLA nanoparticles as a novel carrier for the delivery of anthraquinone: synthesis, characterization and in vitro cytotoxicity evaluation.
    Jeevitha D; Amarnath K
    Colloids Surf B Biointerfaces; 2013 Jan; 101():126-34. PubMed ID: 22796782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raloxifene-encapsulated hyaluronic acid-decorated chitosan nanoparticles selectively induce apoptosis in lung cancer cells.
    Almutairi FM; Abd-Rabou AA; Mohamed MS
    Bioorg Med Chem; 2019 Apr; 27(8):1629-1638. PubMed ID: 30879864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.